These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 33304780

  • 1. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
    Charbe NB, Amnerkar ND, Ramesh B, Tambuwala MM, Bakshi HA, Aljabali AAA, Khadse SC, Satheeshkumar R, Satija S, Metha M, Chellappan DK, Shrivastava G, Gupta G, Negi P, Dua K, Zacconi FC.
    Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK, Singh A, Ganta S, Amiji MM.
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [Abstract] [Full Text] [Related]

  • 4. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S, David S, Faggad A, Chourpa I, Allard-Vannier E.
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X, Li L, Su H, Zhou D, Song H, Wang L, Jiang X.
    Int J Nanomedicine; 2015 Dec; 10():1791-804. PubMed ID: 25784805
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J, Ye Z, Chen M, Liu Z, Xiao Y, Zhang Y, Zhou Y, Tan W, Lang M.
    Biomacromolecules; 2011 Jul 11; 12(7):2562-72. PubMed ID: 21598958
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Charge-reversal nanoparticles: novel targeted drug delivery carriers.
    Chen X, Liu L, Jiang C.
    Acta Pharm Sin B; 2016 Jul 11; 6(4):261-7. PubMed ID: 27471667
    [Abstract] [Full Text] [Related]

  • 15. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment.
    Kang L, Gao Z, Huang W, Jin M, Wang Q.
    Acta Pharm Sin B; 2015 May 11; 5(3):169-75. PubMed ID: 26579443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M, Hu W, Cai C, Wu Y, Li J, Dong S.
    Mater Today Bio; 2022 Mar 11; 14():100223. PubMed ID: 35243298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.